title: Right hepatic lobectomy using the staple technique in 101 patients.
abstract: BACKGROUND
  Application of linear stapling devices for extrahepatic vascular control in liver surgery has been well-established. However, the technique for use of stapling devices in hepatic parenchymal transection is not well defined.
  
  
  OBJECTIVE
  To describe the safety and efficacy of our technique for use of vascular stapling devices in hepatic parenchymal transection during open right hepatic lobectomy is the purpose of this study.
  
  
  METHODS
  We reviewed our experience with 101 consecutive open right hepatic lobectomies performed by a single surgeon between January 2003 and July 2006, in which vascular staplers were utilized for the parenchymal transection phase.
  
  
  RESULTS
  Of the 101 patients who underwent resection, 53 (52%) were female. The mean age was 58 years. Malignant disease was the indication for resection in the majority of patients (88%). Of those with cancer, 78% (69 of 89) had metastatic colorectal cancer, 6% (5 of 89) had metastatic neuroendocrine tumor, 4% (4 of 89) had hepatocellular carcinoma, 4% (4 of 89) had cholangiocarcinoma, and the remaining 8% were other metastatic cancers. Twelve patients (12%) underwent resection for hepatic adenoma or symptomatic benign disease (FNH or hemangioma). Forty-eight patients (48%) underwent a major ancillary procedure at the time of hepatic resection. Thirty-nine patients (39%) had a nonanatomic wedge resection of a left lobe lesion, 27 patients (27%) had one or more lesions treated with radiofrequency ablation (RFA), and 6 patients (6%) were treated with a synchronous bowel resection. The median total operative time was 336 min (range 155-620 min). A Pringle maneuver for temporary vascular inflow occlusion was utilized in all cases, with a median time of 9 min (range 4-17 min). Ten patients (10%) required blood transfusion during surgery or in the postoperative period. The maximum transfusion was 2 U of packed red blood cells (PRBC) in seven patients and 1 U of PRBC in three patients. The mean nadir postoperative hematocrit was 28.2. All patients with malignant disease had tumor-free margins at the completion of the procedure. The average hospital length of stay was 6.0 days. One patient (1%) developed a clinically significant bile leak requiring a postoperative endoscopic retrograde cholangiography (ERCP). No patient required reoperation. The 30 and 60-day postoperative survival was 100%.
  
  
  CONCLUSIONS
  These findings indicate that application of vascular stapling devices for parenchymal transection in major hepatic resection is a safe technique, with low transfusion requirements and minimal postoperative bile leak. The technique allows for rapid transection of the entire right hepatic lobe in under 10 min. Short video clips of the technique will be demonstrated.
authors: UPMC Liver Cancer Center, Thomas E Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA.
authors: Fady K
authors: FK
authors: Balaa
authors: T Clark
authors: TC
authors: Gamblin
authors: Allan
authors: A
authors: Tsung
authors: J Wallis
authors: JW
authors: Marsh
authors: David A
authors: DA
authors: Geller
mesh_terms: D016063:Blood Loss, Surgical / Q000706:statistics & numerical data; D001803:Blood Transfusion / Q000706:statistics & numerical data; D015179:Colorectal Neoplasms / Q000473:pathology; D005260:Female; D006391:Hemangioma / Q000601:surgery; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D007902:Length of Stay; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D017792:Surgical Stapling
references: Arch Surg. 1996 Jan;131(1):104-6
references: 8546569
references: Surgery. 1995 Feb;117(2):140-5
references: 7846617
references: Colorectal Dis. 2004 May;6(3):165-70
references: 15109380
references: Am Surg. 2000 Nov;66(11):1037-40
references: 11090014
references: Am J Surg. 1994 Jul;168(1):49-53
references: 8024098
references: J Am Coll Surg. 2001 Aug;193(2):210-22
references: 11491452
references: HPB (Oxford). 2005;7(3):208-13
references: 18333192
references: J Am Coll Surg. 1994 May;178(5):510-1
references: 8167890
references: Liver Int. 2007 Feb;27(1):26-39
references: 17241378
references: Asian J Surg. 2003 Oct;26(4):193-6
references: 14530102
references: Am J Surg. 1989 Nov;158(5):459-60
references: 2817228
references: Surg Obes Relat Dis. 2006 Nov-Dec;2(6):669
references: 17138242
references: Am J Surg. 2004 Feb;187(2):280-4
references: 14769320
references: J Chir (Paris). 1990 Jun-Jul;127(6-7):356-8
references: 2211893
references: Surg Endosc. 2004 Jun;18(6):961-3
references: 15108116
references: Br J Surg. 1991 Jan;78(1):40-1
references: 1998861
references: J Urol. 1993 Jun;149(6):1437-9; discussion 1439-40
references: 8501782
references: ANZ J Surg. 2003 Nov;73(11):922-5
references: 14616571
references: J Am Coll Surg. 1997 Jul;185(1):93-100
references: 9208969
references: Surg Obes Relat Dis. 2006 Jul-Aug;2(4):431-4
references: 16925374
references: Am J Surg. 1996 Oct;172(4):358-62
references: 8873530
references: J Exp Clin Cancer Res. 1999 Sep;18(3):299-303
references: 10606173
references: Am J Surg. 2005 Jul;190(1):23-9
references: 15972166
references: Obes Surg. 2003 Dec;13(6):855-9; discussion 860
references: 14738669
references: Obes Surg. 2006 Dec;16(12):1559-62
references: 17217629
references: Surg Technol Int. 1998;7:43-7
references: 12721961
references: J Invest Surg. 1997 Jan-Apr;10(1-2):59-61
references: 9100177
references: World J Surg. 2006 Mar;30(3):419-30
references: 16467982
references: Anticancer Res. 2003 Mar-Apr;23(2C):1697-700
references: 12820443
references: S Afr J Surg. 1992 Jun;30(2):47-8
references: 1519125